期刊文献+

两性霉素B缓释微球的制备及缓释性能研究 被引量:10

Preparation and in vitro Release Behavior of Amphotericin B Loaded PLA-PEG Microspheres
暂未订购
导出
摘要 为了更好地研究药物载体材料对药物微球缓释性能的影响,本研究将可完全生物降解的共聚物作为壁材以相分离法制备含抗真菌药物两性霉素B的微球,研究了不同溶剂/非溶剂、不同分子量共聚物、不同配比共聚物、不同表面活性剂及其不同用量等因素对微球的粒径大小、分布、药物包封率和药物体外释放等性能的影响。使用透射电镜(TEM)和原子力显微镜(AFM)观察微球的表面形貌,使用激光粒度分析仪测试微球的粒径大小及分布,使用紫外分光光度计测定药物的包封率。研究发现,聚合物特性粘度和分子量越大,聚合物中LA:PEG的配比越大,微球粒径越大,分布越宽;微球粒径越大,包封率也较大;AmB/PLA-PEG微球具有缓释性能,且含药微球的释放性能与微球的粒径,包封率等因素有关。 Amphotericin B (AmB)-loaded poly (lactic acid)-poly (ethylene glycol) (PLA-PEG) microspheres were prepared by phase separation. The effect of the solvent/nonsolvent system, the composition of copolymer and the dosage of the Tween-80 on the size, the entrapment efficiency and the release behavior of the AmB loaded microspheres were investigated. The morphology of microspheres was characterized by atomic force microscopy (AFM) and transmission electron microscopy (TEM) respectively. The average particle size and size distribution were measured by laser light scattering technique. The entrapment ratio of AmB by microspheres was measured by UV spectrophotometer. It was found the microspheres size increased with the increase of LA/PEG weight ratio and the molecular weight of PEG segment in the PLA-PEG. The entrapment efficiency of AmB in PLA-PEG microspheres became higher and release rate became slower with the increase of LA/PEG ratio and addition of Tween-80.
出处 《中国生物医学工程学报》 CAS CSCD 北大核心 2007年第3期445-451,共7页 Chinese Journal of Biomedical Engineering
基金 上海市科委纳米专项基金(0452nm059) 同济大学工科基金。
关键词 聚乳酸-聚乙二醇共聚物 微球 相分离法 缓释 PLA-PEG copolymer, microsphere, nanoprecipitation, controlled release
  • 相关文献

参考文献15

  • 1Walsh TJ,Pizzo A.Treatment of systemic fungal infections:recent progress and currentproblems[J].Eur J Clin Microbiol Infect Dis,1988,7:460-475.
  • 2Kassab R,Parrot-Lopez H.Molecular recognition by kluyveromyces of amphotericin B-loaded,galactose-tagged,polylactic acid microspheres[J].Bioorg Med Chem,2002,10:1767-1775.
  • 3Adler-Moore J,Proffitt RT.AmBisome:liposomalformulation,structure,mechanism of action and pre-clinical experience[J].J Antimicrob Chemother,2002,49:21-30.
  • 4Koike FH,Saheki T.A novel delivery system for amphotericin B with lipid nano-sphere(LNS(R))[J].Int J Pharm,2003,265:37-45.
  • 5赵荣生,严宝霞,侯新朴.两性霉素B脂质体的研制及其质量评价[J].中国药学杂志,2000,35(9):593-595. 被引量:20
  • 6Adams ML,Glen S.Kwon.Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles:effects of acyl chain length[J].J Controll Rel,2003,87:23-32.
  • 7Gulyacv AE,Gelperina SE,Skidan IN,et al.Significant transport of of doxorubicin into the brain with polysorbate 80-coated nanoparticles[J].Pharm Res,1999,16(10):1564-1569.
  • 8Johnson OL,Jaworowicz W,Ctetand JL,et al.The stabilization and encapsutation of human growth hormone into biodegradable microsphere[J].Pharm Res,1997,14:730-736.
  • 9Sacchetti C,Artusi M,Santi P,et al.Caffeine microparticles for nasal administration obtained by spray drying[J].Internati J of Pharm,2002,242:335-339.
  • 10张子勇,陈燕琼.丙交酯单体的制备及纯化[J].高分子材料科学与工程,2003,19(2):52-56. 被引量:50

二级参考文献8

  • 1WANGYuan-liang ZHAOJian-hua.重庆大学学报 (Journal Chongqing University),1996,19(1):112-112.
  • 2FANChang-lie LIBing LIUZhen-hua.高等学校化学学报 (Chemical Journal Chinese University),1995,16(6):971-971.
  • 3ZHANGZhen-yu SUYi-hua ZHANGYan-hong.黑龙江大学自然科学学报(Journal Heilonjiang University, Nature Science Edition),15(1):110-110.
  • 4LUZe-jian LIAOKai-rong LIHong-quan.中山大学学报(自然科学版) (Journal Zhongshan University, Nature Science Edition),38(5):36-36.
  • 5SONGMou-dao ZHUJie-liang ZHANGBang-hua.高分子学报 (Acta Polymerica Sinica),1998,4:454-454.
  • 6[1] Leenders ACAP, Marie SD. The use of lipid formulation of amphotericin B for systemic fungal infectious[J].Leukemia, 1996, 10:1570.
  • 7[2] Jill PA, Richard TP. Development, characterization, efficacy and mode of action of ambisome,a unilamellar liposomal formulation of amphotericin B[J].Journal of liposome Research,1993,3(3):429.
  • 8[3] Marie SD. Liposomal and lipid-based formulations of amphotericin B[J].Leukemia,1996,10(Suppl.2):S93.

共引文献68

同被引文献150

引证文献10

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部